RxDoctor Payments Data

James Rahto, MD

Family Medicine · Overland Park, KSNPI 1902892862

Payments from drug & device makers

$10,743in general payments, 2019–2025

Across 649 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • Lilly USA, LLC$915
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$895
  • Amgen$578
  • Boehringer Ingelheim$553
  • plus $5K from 51 others

What the payments were for

  • Food & beverage$10,743100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)98$1,644
Novo Nordisk83$1,152
Lilly USA, LLC53$915
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC62$895
Amgen36$578
Boehringer Ingelheim31$553
GSK14$399
Pfizer26$347
AstraZeneca21$336
Merck24$303
Antares Pharma, Inc.15$288
Abbott12$232
Otsuka America Pharmaceutical, Inc.10$220
Supernus Pharmaceuticals, Inc.14$205
Teva Pharmaceuticals USA, Inc.12$203
Phathom Pharmaceuticals, Inc.9$150
Boston Scientific1$149
Novartis10$147
Johnson & Johnson10$147
Corium, LLC8$127
Takeda Pharmaceuticals U.S.A., Inc.9$124
Astellas Pharma US Inc6$117
Dexcom, Inc.6$111
Amarin Pharma, Inc.6$103
Bayer5$92
Axsome Therapeutics, Inc.5$92
IBSA Pharma Inc.5$89
Hologic Sales And Service, LLC5$87
Sanofi-aventis U.S. LLC5$86
Biohaven Pharmaceuticals, Inc.3$62
Cranial Technologies, Inc4$56
Biohaven Pharmaceutical Holding Company Ltd.2$56
Clarus Therapeutics Inc.3$56
Idorsia Pharmaceuticals US Inc3$52
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$44
Shield Therapeutics Inc2$43
Currax Pharmaceuticals LLC3$39
Shire North American Group Inc3$36
Ardelyx, Inc.2$35
Neos Therapeutics, LP2$34
Eisai Inc.2$34
Gilead1$28
Upsher-smith Laboratories LLC1$28
Sumitomo Pharma America, Inc.1$27
Ironwood Pharmaceuticals, Inc2$25
Biogen1$23
Ascendis Pharma Endocrinology Inc1$22
Apria Healthcare LLC1$18
Exeltis, USA Inc.1$17
Forte Bio-pharma LLC1$17
Protega Pharmaceutials Inc1$17
Misonix Inc1$15
Evofem Biosciences, Inc.1$14
Bausch Health US, LLC1$14
Corcept Therapeutics1$14
Arbor Pharmaceuticals, Inc.1$14
Nalpropion Pharmaceuticals LLC1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,743 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$93,817
Medicare patients
218
Services billed
2,608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide65$68,710
MounjaroTirzepatide49$53,764
JardianceEmpagliflozin38$37,550
EliquisApixaban27$25,235
MyrbetriqMirabegron13$13,619
XareltoRivaroxaban12$8,903
Rosuvastatin Calcium274$3,772
Testosterone Cypionate54$2,732
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C16$2,243
Famotidine109$1,698
Levothyroxine Sodium152$1,438
SynthroidLevothyroxine Sodium21$1,322
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine52$1,161
Tamsulosin Hcl110$1,053
Atorvastatin Calcium181$1,048

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,152$68,71065 claims
Lilly USA, LLCMounjaro$915$53,76449 claims
Boehringer IngelheimJardiance$553$37,55038 claims
PfizerEliquis$347$25,23527 claims
Astellas Pharma US IncMyrbetriq$117$13,61913 claims
Johnson & JohnsonXarelto$147$8,90312 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu$895$2,24316 claims
AbbVieSynthroid$1,644$1,32221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →